NASDAQ:TCDA • US89610F1012
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TRICIDA INC (TCDA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-10-25 | Needham | Downgrade | Buy -> Hold |
| 2022-10-25 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-10-24 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-05-11 | Goldman Sachs | Maintains | Buy |
| 2022-04-13 | Goldman Sachs | Initiate | Buy |
| 2021-11-16 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||||
| EBITDA YoY % growth | -26.76M | -46.78M -74.81% | -102.98M -120.14% | -178.06M -72.91% | -250.5M -40.68% | -152.512M 39.12% | N/A 34.46% | N/A 55.10% | N/A | |
| EBIT YoY % growth | -27.18M | -47.12M -73.36% | -103.6M -119.86% | -178.82M -72.61% | -251.4M -40.59% | -152.954M 39.16% | N/A 29.09% | N/A 47.29% | N/A 19.98% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -3.71 26.12% | -5.24 -41.24% | -3.32 36.64% | N/A 38.93% | N/A 46.12% | N/A 17.32% |
All data in USD
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 43.60% | -0.46 10.00% | -0.38 22.98% | -0.28 36.25% | -0.21 58.72% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | -20.4M 55.09% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -22.185M 51.63% | N/A | N/A | N/A | N/A |
All data in USD
8 analysts have analysed TCDA and the average price target is 19.72 USD. This implies a price increase of 18159.26% is expected in the next year compared to the current price of 0.108.
TRICIDA INC (TCDA) will report earnings on 2023-03-27.
The consensus EPS estimate for the next earnings of TRICIDA INC (TCDA) is -0.52 USD and the consensus revenue estimate is 0 USD.
The number of analysts covering TRICIDA INC (TCDA) is 8.